Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-073075
Filing Date
2024-06-13
Accepted
2024-06-13 16:30:16
Documents
1
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3947
  Complete submission text file 0000950170-24-073075.txt   5409
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address
Ray Sumita (Reporting) CIK: 0001579629 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40335 | Film No.: 241041665

Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Issuer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)